Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial-Reference-Cited by-同舟云学术

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Published:2020-04-22 Issue:4 Volume:17 Page:e1003095
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Tanaka Atsushi^ORCID,Taguchi Isao,Teragawa Hiroki^ORCID,Ishizaka Nobukazu,Kanzaki Yumiko^ORCID,Tomiyama Hirofumi,Sata Masataka,Sezai Akira,Eguchi Kazuo^ORCID,Kato Toru^ORCID,Toyoda Shigeru^ORCID,Ishibashi Ryoichi^ORCID,Kario Kazuomi^ORCID,Ishizu Tomoko^ORCID,Ueda Shinichiro^ORCID,Maemura Koji,Higashi Yukihito,Yamada Hirotsugu^ORCID,Ohishi Mitsuru,Yokote Kotaro,Murohara Toyoaki^ORCID,Oyama Jun-ichi^ORCID,Node Koichi^ORCID,

Funder

Teijin Pharma Limited, Japan

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference34 articles.

1. Serum uric acid: a risk factor and a target for treatment?;DI Feig;J Am Soc Nephrol,2006

2. Uric acid and cardiovascular risk;DI Feig;N Engl J Med,2008

3. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study;M Kuwabara;Hypertension,2017

4. Improving cardiovascular and renal outcomes in gout: what should we target?;P Richette;Nat Rev Rheumatol,2014

5. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications;P Puddu;J Cardiol,2012

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28

2. Effects of Xanthine Oxidase Inhibition by Febuxostat on Lipid Profiles of Patients with Hyperuricemia: Insights from Randomized PRIZE Study;Nutrients;2024-07-19

3. Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases;Journal of Hypertension;2024-07-10

4. Uric acid and cardiovascular diseases: a reappraisal;Postgraduate Medicine;2024-07-09

5. Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study;Journal of Atherosclerosis and Thrombosis;2024-06-01